Pathstone Holdings LLC reduced its stake in Centene Co. (NYSE:CNC – Free Report) by 0.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,677 shares of the company’s stock after selling 291 shares during the quarter. Pathstone Holdings LLC’s holdings in Centene were worth $3,137,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the company. Park Place Capital Corp lifted its holdings in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after purchasing an additional 357 shares during the last quarter. WR Wealth Planners LLC boosted its position in shares of Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after acquiring an additional 137 shares during the period. Chris Bulman Inc bought a new position in Centene during the second quarter worth about $33,000. Riverview Trust Co raised its stake in Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after purchasing an additional 320 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Centene during the 2nd quarter worth approximately $36,000. Institutional investors own 93.63% of the company’s stock.
Analyst Upgrades and Downgrades
CNC has been the subject of a number of analyst reports. Wells Fargo & Company dropped their price target on shares of Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Stephens reissued an “equal weight” rating and set a $78.00 target price on shares of Centene in a report on Monday, August 5th. Oppenheimer dropped their price target on Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, July 29th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Finally, Sanford C. Bernstein cut their price target on shares of Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a report on Wednesday, October 30th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Centene has an average rating of “Moderate Buy” and a consensus target price of $83.92.
Insider Transactions at Centene
In other Centene news, CEO Sarah London acquired 4,117 shares of Centene stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $60.80 per share, with a total value of $250,313.60. Following the completion of the purchase, the chief executive officer now directly owns 667,229 shares in the company, valued at $40,567,523.20. This trade represents a 0.62 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Andrew Lynn Asher bought 17,200 shares of the business’s stock in a transaction on Wednesday, November 13th. The shares were bought at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now directly owns 486,847 shares in the company, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.33% of the company’s stock.
Centene Trading Up 0.0 %
Shares of CNC stock opened at $60.37 on Monday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $30.48 billion, a P/E ratio of 10.48, a P/E/G ratio of 0.83 and a beta of 0.49. Centene Co. has a twelve month low of $57.20 and a twelve month high of $81.42. The stock’s fifty day simple moving average is $66.68 and its 200 day simple moving average is $70.43.
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
- Five stocks we like better than Centene
- How to Calculate Return on Investment (ROI)
- Disney’s Magic Strategy: Reinventing the House of Mouse
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.